Introduction
Ghrelin is one of the most important gut hormones in metabolic and growth hormone research. As the endogenous ligand for the GHS-R1a receptor, it mediates hunger signaling, growth hormone release, and a range of metabolic functions. Understanding ghrelin’s biology provides essential context for research with GHRP compounds and other GHS-R1a agonists.
Discovery and Structure
Ghrelin was discovered in 1999 by Masayasu Kojima and colleagues in Japan, identified as the endogenous ligand for the previously orphaned growth hormone secretagogue receptor (GHS-R1a). It is a 28-amino acid peptide with a unique and essential posttranslational modification — octanoylation of serine at position 3. This n-octanoic acid side chain is required for GHS-R1a binding and GH-releasing activity; des-acyl ghrelin (without the octanoyl modification) does not activate GHS-R1a.
Production and Regulation
Ghrelin is produced primarily by specialized X/A-like cells (also called P/D1 cells) in the gastric fundus. Plasma ghrelin levels rise sharply before meals and fall after eating, establishing it as a hunger hormone that anticipates and initiates meals. Ghrelin levels are also elevated by caloric restriction, weight loss, and fasting, and are reduced by obesity and high-fat feeding. Sleep deprivation increases ghrelin levels, providing a potential mechanism connecting sleep insufficiency to increased appetite.
GHS-R1a Signaling
Ghrelin acts through GHS-R1a (also called the growth hormone secretagogue receptor type 1a), a GPCR highly expressed in the pituitary, hypothalamus, and other brain regions. GHS-R1a couples primarily to Gq, activating phospholipase C and increasing intracellular calcium. It also activates Gi-mediated pathways. GHS-R1a has unusually high constitutive activity — it maintains substantial signaling even without ghrelin bound, making it sensitive to inverse agonists like LEAP2.
GH-Releasing Effects
Ghrelin is a potent stimulator of GH release from the pituitary through GHS-R1a activation. It acts synergistically with GHRH — the combination of ghrelin (or GHRP mimetics) and GHRH produces much greater GH release than either alone. This is because GHRH increases GH pulse amplitude through pituitary GHRH receptors while ghrelin/GHRPs increase pulse frequency through GHS-R1a. Synthetic ghrelin mimetics (GHRPs) were developed before ghrelin itself was discovered, and their pharmacology predicted ghrelin’s existence and mechanism.
Appetite and Metabolic Effects
Ghrelin’s hunger-stimulating effects are mediated through GHS-R1a in the hypothalamic arcuate nucleus, where it activates NPY/AgRP neurons that promote food intake and suppress energy expenditure. These are the same neurons inhibited by leptin — ghrelin and leptin function as opposing hormonal regulators of energy balance. Ghrelin also influences gastric motility, adipogenesis, glucose metabolism, and reward circuits related to food motivation.
Synthetic Ghrelin Mimetics (GHRPs)
The GHRP compounds used in research — GHRP-6, GHRP-2, Ipamorelin, Hexarelin — are all synthetic ghrelin mimetics that activate GHS-R1a. Their differential effects on cortisol, prolactin, and appetite reflect different activation profiles at GHS-R1a and potentially at other receptors. Ipamorelin’s selectivity for GH release without appetite stimulation or cortisol elevation suggests it engages GHS-R1a in a way that preferentially activates GH-releasing signaling over appetite-regulating signaling — a concept related to biased agonism at the receptor.
Conclusion
Ghrelin is a multifunctional gut hormone that regulates GH release, appetite, and metabolism through GHS-R1a. Its discovery validated the GHS receptor pharmacology that had been characterized through synthetic GHRP compounds for more than a decade, and its unique octanoyl modification, constitutively active receptor, and opposing relationship with leptin make it one of the most scientifically interesting hormones in metabolic research.